Compare COO & XPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | XPO |
|---|---|---|
| Founded | 1980 | 2000 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 16.3B |
| IPO Year | N/A | N/A |
| Metric | COO | XPO |
|---|---|---|
| Price | $83.48 | $203.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 18 |
| Target Price | $89.64 | ★ $169.12 |
| AVG Volume (30 Days) | 1.6M | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.59 | $5.22 |
| Revenue Next Year | $5.36 | $6.57 |
| P/E Ratio | ★ $44.60 | $76.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.78 | $85.06 |
| 52 Week High | $92.82 | $207.77 |
| Indicator | COO | XPO |
|---|---|---|
| Relative Strength Index (RSI) | 57.16 | 71.80 |
| Support Level | $80.51 | $185.66 |
| Resistance Level | $84.23 | $207.00 |
| Average True Range (ATR) | 2.07 | 10.32 |
| MACD | 0.19 | 2.28 |
| Stochastic Oscillator | 86.12 | 93.71 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.